Eastman Kodak Company Q1 FY2026 earnings call

• The first quarter story is one of consistency, stability, and growth, reflecting transformation over seven years and focus on execution and investment. - In AM and C, heavy investment in film is showing results, like launching professional still film for distributors and Motion Picture film being used in various productions including Euphoria season three and Oscar-winning movies. The new CGMP pharmaceutical manufacturing facility is operational, and the Advanced Electrophysiology Lab with SUNY Geneseo is opened. - In commercial print business, revenue increased 9% despite supply issues on aluminum, delivery/logistics issues, and raw material price increases, and the Sonora Ultra XR Plate was launched in Europe. - Focus on manufacturing, selling, and service to deliver long-term value to shareholders, customers, and employees.

Consolidated revenue was $265 million, up 7% from $247 million in Q1 2025. Print business revenue increased by 9%. Advanced Materials and Chemicals (AM and C) revenue grew by $2 million, or 3%, driven by a $3 million increase in film and chemicals, partially offset by $1 million lower in inks and consumables. AM and C contributed a certain percentage to total revenue.

• Sharp commodity swings and persistent inflationary pressure. - Supply issues on aluminum, delivery and logistics problems. - The change in fair value of an embedded derivative related to Series B preferred stock could impact results. - Pension income is expected to be lower year over year due to the termination of the CREP pension plan.